Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen issues early data on potential game-changing MS drug. Investors shrug.
Biogen issues early data on potential game-changing MS drug. Investors shrug.
Biogen issues early data on potential game-changing MS drug. Investors shrug.
Submitted by
admin
on January 8, 2015 - 2:48pm
Source:
Bizjournals.com
News Tags:
Biogen Idec
MS
multiple sclerosis
anti-LINGO-1
Headline:
Biogen issues early data on potential game-changing MS drug. Investors shrug.
Do Not Allow Advertisers to Use My Personal information
